Minerva Neurosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NERV and other ETFs, options, and stocks.About NERV
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease.
CEORémy Henri Luthringer
CEORémy Henri Luthringer
Employees8
Employees8
HeadquartersBurlington, Massachusetts
HeadquartersBurlington, Massachusetts
Founded2007
Founded2007
Employees8
Employees8
NERV Key Statistics
Market cap28.67M
Market cap28.67M
Price-Earnings ratio-2.22
Price-Earnings ratio-2.22
Dividend yield—
Dividend yield—
Average volume95.71K
Average volume95.71K
High today$4.21
High today$4.21
Low today$3.75
Low today$3.75
Open price$3.75
Open price$3.75
Volume89.93K
Volume89.93K
52 Week high$12.46
52 Week high$12.46
52 Week low$1.15
52 Week low$1.15
Stock Snapshot
With a market cap of 28.67M, Minerva Neurosciences(NERV) trades at $4.11. The stock has a price-to-earnings ratio of -2.22.
During the trading session on 2025-11-15, Minerva Neurosciences(NERV) shares reached a daily high of $4.21 and a low of $3.75. At a current price of $4.11, the stock is +9.6% higher than the low and still -2.4% under the high.
Trading activity shows a volume of 89.93K, compared to an average daily volume of 95.71K.
Over the past 52 weeks, Minerva Neurosciences(NERV) stock has traded between a high of $12.46 and a low of $1.15.
Over the past 52 weeks, Minerva Neurosciences(NERV) stock has traded between a high of $12.46 and a low of $1.15.
People also own
Based on the portfolios of people who own NERV. This list is generated using Robinhood data, and it’s not a recommendation.